Chemomab Therapeutics (CMMB) Insider Trading & Ownership → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free CMMB Stock Alerts $0.67 0.00 (0.00%) (As of 01:16 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Chemomab Therapeutics (NASDAQ:CMMB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage11.91%Number OfInsiders Buying(Last 3 Years)4Amount OfInsider Buying(Last 3 Years)$61,935.00Number OfInsiders Selling(Last 3 Years)3Amount OfInsider Selling(Last 3 Years)$1.89 M Get CMMB Insider Trade Alerts Want to know when executives and insiders are buying or selling Chemomab Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CMMB Insider Buying and Selling by Quarter Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 Chemomab Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/3/2023Israel Gp Ltd. OrbimedMajor ShareholderSell336,900$3.58$1,206,102.00 11/16/2022George Adi MorInsiderSell324,775$2.08$675,532.00 11/16/2022Neil Harris CohenDirectorSell2,409$2.00$4,818.00 3/18/2022Joel Michael MarylesDirectorBuy1,000$4.34$4,340.00 3/16/2022Donald MarvinCFOBuy500$3.27$1,635.00 3/14/2022Dale R PfostCEOBuy2,500$3.98$9,950.00 3/14/2022Donald MarvinCFOBuy1,250$4.04$5,050.00 3/14/2022Neil Harris CohenDirectorBuy6,000$4.35$26,100.00 12/6/2021Neil Harris CohenDirectorBuy2,000$7.43$14,860.00 (Data available from 1/1/2013 forward) CMMB Insider Trading Activity - Frequently Asked Questions Who is on Chemomab Therapeutics's Insider Roster? The list of insiders at Chemomab Therapeutics includes Dale R Pfost, Donald Marvin, George Adi Mor, Israel Gp Ltd. Orbimed, Joel Michael Maryles, and Neil Harris Cohen. Learn more on insiders at CMMB. What percentage of Chemomab Therapeutics stock is owned by insiders? 11.91% of Chemomab Therapeutics stock is owned by insiders. Learn more on CMMB's insider holdings. Which Chemomab Therapeutics insiders have been selling company stock? The following insiders have sold CMMB shares in the last 24 months: George Adi Mor ($675,532.00), Israel Gp Ltd. Orbimed ($1,206,102.00), and Neil Harris Cohen ($4,818.00). How much insider selling is happening at Chemomab Therapeutics? Insiders have sold a total of 664,084 Chemomab Therapeutics shares in the last 24 months for a total of $1,886,452.00 sold. More Insider Trading Tools from MarketBeat Related Companies: EFTR Insider Trading TRVN Insider Trading KTTA Insider Trading GRAY Insider Trading SBFM Insider Trading LIXT Insider Trading CLVR Insider Trading ENVB Insider Trading SHPH Insider Trading HILS Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:CMMB) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersPentagon contract could send this $2 AI stock soaringBehind the MarketsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemomab Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
